Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$105K Buy
291
+249
+593% +$85.2K 0.03% 201
2026
Q1
$14.8K Buy
+42
New +$15K ﹤0.01% 409

Other funds holding AMGN

Gill Capital Partners's AMGN Position: Q2 2026 in Review

Gill Capital Partners increased its Amgen (AMGN) stake by 593% in Q2 2026, buying an estimated $85.2K and bringing the position to 291 shares worth $105K. The position accounts for 0.03% of the portfolio, ranked #201.

Gill Capital Partners first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Gill Capital Partners held 291 shares of Amgen worth $105K as of Q2 2026.
  • Gill Capital Partners bought 249 Amgen shares in Q2 2026, an estimated $85.2K.
  • Amgen made up 0.03% of Gill Capital Partners's portfolio in Q2 2026, its #201 holding.
  • Gill Capital Partners first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Gill Capital Partners's 13F filing for Q2 2026, filed 20 Aug 2026.